HIF-1α-induced long noncoding RNA LINC02776 promotes drug resistance of ovarian cancer by increasing polyADP-ribosylation

Yangjun Wu , Yu Zeng , Yong Wu , Xinyu Ha , Zheng Feng , Chaohua Liu , Ziqi Liu , Jiajia Wang , Xingzhu Ju , Shenglin Huang , Linhui Liang , Bin Zheng , Lulu Yang , Jun Wang , Xiaohua Wu , Shengli Li , Hao Wen

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (3) : e70244

PDF
Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (3) : e70244 DOI: 10.1002/ctm2.70244
RESEARCH ARTICLE

HIF-1α-induced long noncoding RNA LINC02776 promotes drug resistance of ovarian cancer by increasing polyADP-ribosylation

Author information +
History +
PDF

Abstract

•LINC02776 promotes OC cell proliferation by regulating DNA damage and apoptosis signaling pathways.

•LINC02776 binds PARP1 to promote DNA damage-triggered PARylation in OC cells.

•LINC02776 mediates cisplatin and olaparib resistance in OC cells by enhancing PARP1-mediated PARylation activity and regulating the PARP1-mediated HR pathway.

•The high expression of LINC02776 is induced by HIF-1α in platinum-resistant OC cells and tissues.

Keywords

HIF-1α / LINC02776 / ovarian cancer / PARP1 / PARPi resistance / platinum resistance

Cite this article

Download citation ▾
Yangjun Wu, Yu Zeng, Yong Wu, Xinyu Ha, Zheng Feng, Chaohua Liu, Ziqi Liu, Jiajia Wang, Xingzhu Ju, Shenglin Huang, Linhui Liang, Bin Zheng, Lulu Yang, Jun Wang, Xiaohua Wu, Shengli Li, Hao Wen. HIF-1α-induced long noncoding RNA LINC02776 promotes drug resistance of ovarian cancer by increasing polyADP-ribosylation. Clinical and Translational Medicine, 2025, 15(3): e70244 DOI:10.1002/ctm2.70244

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

116

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/